Back to search

Article

CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade

2023-11-14

Abstract excerpt

<title>Abstract</title> <p>The promise of immunotherapy to induce long-term durable responses in conventionally treatment resistant tumors like glioblastoma (GBM) has given hope for patients with a dismal prognosis. Yet, few patients have demonstrated a significant survival benefit despite multiple clinical trials designed to invigorate immune recognition and tumor eradication. Insights gathered over the last two...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
386d0339-450c-5cbf-9456-ecd541b03beb
DOI
10.21203/rs.3.rs-3463730/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockadeDOI 10.21203/rs.3.rs-3463730/v1
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.Semantic proximity
Virus-Based Therapies for the Treatment of Recurrent High-Grade GliomaSemantic proximity
Engineered AAV9 as <i>in vivo</i> gene delivery platform for the selective transduction of TME cell subsetsSemantic proximity
T-Cell-Mediated Killing in Glioblastoma Organoids induced by Adenoviral Delivery of the CIITA TransgeneSemantic proximity
A non-randomized, open-label, dose-finding, first-in-human trial of combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: transgene expression persists up to 17 months post-vector injectionSemantic proximity
Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapySemantic proximity
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunitySemantic proximity
Strategies in Gene Therapy for GlioblastomaSemantic proximity
Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principleSemantic proximity
Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escapeSemantic proximity
Intratumoral delivery of engineered recombinant modified vaccinia virus Ankara expressing Flt3L and OX40L generates potent antitumor immunity through activating the cGAS/STING pathway and depleting tumor-infiltrating regulatory T cellsSemantic proximity
IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastomaSemantic proximity
Select a neighboring publication to make it the new centre.